Related Experiment Video
Updated: Jun 7, 2025
Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
Published on: July 4, 2018
A Pilot Study of Urine Oxytocin as an Objective Biomarker for Chronic Pain
Daisuke Ono1, Takashi Matsusaki1, Yoshikazu Matsuoka2
1Department of Anesthesiology, Mie University Hospital, Tsu, Mie, Japan.
Background:
Measuring pain objectively or quantitatively is difficult. Since urine oxytocin (OXT) concentration has been reported to be potentially associated with chronic pain.
Purpose:
We conducted a pilot study to evaluate the relationship between changes in numerical rating scale (NRS) score following nerve block and urine OXT concentration in patients with chronic pain.
Methods:
We investigated 19 chronic pain patients who were admitted to our hospital for nerve intervention. NRS score and urine OXT concentration were assessed before and after the nerve block.
Results:
NRS scores were 7 [6, 9] and 2 [1, 4] (median [interquartile range]) before and after the treatment intervention, respectively. Urinary OXT levels were 523 [293, 743] and 531 [308, 887] pg/mL (median [interquartile range]) before and after the treatment, respectively. We compared the group with greater improvement in NRS after the treatment intervention and those with less improvement. The group with greater improvement in NRS after the treatment intervention showed a greater increase in OXT level. However, baseline urine OXT concentrations were highly variable in patients with chronic pain and the changes in urinary OXT concentrations were also variable.
Conclusion:
Based on this pilot study, the utility of urine OXT concentration as an objective biomarker of chronic pain needs further investigation.
